Prolacta Bioscience

United States
Los Angeles, California, United States, 91746

Company profile

Prolacta Bioscience company profile

Prolacta Bioscience, Inc. (www.prolacta.com) is a life science company founded by serial entrepreneur, Elena Medo who has dedicated her career to improving quality of life for sick infants by Advancing the Science of Human MilkTM. Prolacta creates specialty formulations made exclusively from human milk for the nutritional needs of critically ill, premature infants in neonatal intensive care units. It is the first and only company to provide a human milk fortifier made from 100% human milk, Prolact+ H2MF. They operate a pharmaceutical grade processing plant and have designed and patented processes that enable them to make their one-of-a-kind life saving products. Prolacta is committed to making a meaningful difference in the lives of the most vulnerable infants through world-class research and innovative products.

Business identity

Contact email
[email protected]
Phone number
6265999269
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$0-$1M
Founded
1999-01-01, Year

Headquarters

Postal code
91746
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
7
Total equity funding
$78M
Last funding
Series Unknown / $8.9M / 2018-05-15
Last equity funding
Series Unknown / $8.9M
Investors
13
Lead investors
3
Founders
1
Articles
71

Founders and investors

Founders

Elena Medo

Lead investors

Alta PartnersEssex Woodlands Healthcare PartnersHealth Evolution Partners

Investors

Aisling CapitalAlta PartnersDraper AssociatesPROOFRevelation Partners